Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 8
Submit an article Journal homepage
50
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Immune Reconstitution Inflammatory Syndrome Mimicking Relapse of AIDS Related Lymphoma in Patients with HIV 1 Infection

T. Powles Departments of Oncology and HIV medicine Chelsea and Westminster Hospital 369 Fulham Road, SWNH 10 9 London UK
,
C. Thirlwell Departments of Oncology and HIV medicine Chelsea and Westminster Hospital 369 Fulham Road, SWNH 10 9 London UK
,
M. Nelson Departments of Oncology and HIV medicine Chelsea and Westminster Hospital 369 Fulham Road, SWNH 10 9 London UK
&
M. Bower Departments of Oncology and HIV medicine Chelsea and Westminster Hospital 369 Fulham Road, SWNH 10 9 London UK
Pages 1417-1419 | Published online: 01 Jul 2009

References

  • Shelburne, S.A., ifi, Hamill, R.J., Rodriguez-Barradas, MC., Greenberg, S.B., Atmar, R.L., Musher, D.W., Gathe, J.C., Jr. Visnegarwala, F. and Trautner, B.W. (2002) "Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy", Medicine (Baltimore) 81(3), 213–227.
  • Race, EM., Adelson-Mitty, J., Kriegel, G.R., Barlam, T.F., Reimann, K.A., Letvin, N.L. and Japour, A.J. (1998) "Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease", Lancet 351(9098), 252–255.
  • Phillips, P., Kwiatkowski, MB., Copland, M., Craib, K. and Montaner, J. (1999) "Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy", Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 20(2), 122–128.
  • Cabie, A., Abel, S., Brebion, A., Desbois, N. and Sobesky, G. (1998) "Mycobacterial lymphadenitis after initiation of highly active antiretroviral therapy", European Journal of Clinical Microbiology and Infectious Disease 17(11), 812–813.
  • Narita, M., Ashkin, D., Hollender, ES. and Pitchenik, A.E. (1998) "Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS", American Journal of Respiratory and Critical Care Medicine 158(1), 157–161.
  • Fishman, J.E., Saraf-Lavi, E., Narita, M., Hollender, ES., Ramsinghani, R. and Ashkin, D. (2000) "Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy", AJR American Journal of Roentgenology 174(1), 43–49.
  • Jacobson, M.A., Zegans, M., Pavan, P.R., O'Donnell, J.J., Sattler, F., Rao, N., Owens, S. and Pollard, R. (1997) "Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy", Lancet 349(9063), 1443–1445.
  • Woods, M.L., II, MacGinley, R., Eisen, D.P. and Allworth, A.M. (1998) "Mr combination therapy: partial immune restitution unmasking latent cryptococcal infection", Aids 12(12), 1491–1494.
  • Powles, T., Matthews, G. and Bower, M. (2000) "AIDS related systemic non-Hodgkin's lymphoma", Sexually Transmitted Infect-ions 76(5), 335–341.
  • Autran, B., Carcelain, G., Li, T.S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debre, P. and Leibowitch, J. (1997) "Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease", Science 277(5322), 112–116.
  • Palella, F.J., Jr. Delaney, K.M., Moorman, A.C., Loveless, no., Fuhrer, J., Satten, G.A., Aschman, D.J. and Holmberg, S.D. (1998) "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators", New England Journal of Medicine 338(13), 853–860.
  • Lederman, MM. (2001) "Immune restoration and CD4+ T-cell function with antiretroviral therapies", Aids 15, Sll — S15.
  • Carcelain, G., Debre, P. and Autran, B. (2001) "Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy", Current Opinion in Immunology 13(4), 483–488.
  • Powles, T., hnami, N., Nelson, M., Gazzard, B.G. and Bower, M. (2002) "Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma", Aids 16(4), 531–536.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.